Money Management, Australia -Idenix Pharmaceuticals plunged 38 per cent after drug regulators suspended clinical study of the biopharmaceutical company's hepatitis C drug because ...<br><img src="/images/chart_7777cc3.gif" class="ticker-icon" width="14" height="12"><a href="http://finance.google.com/finance?q=GE&client=news" class="rich">GE</a><a href="http://timesofindia.indiatimes.com/Business/India_Business/Pharma_industry_charts_strategies_to_tackle_rising_Re_impact/articleshow/2205989.cms" id=r-8_1118212609>Pharma industry charts strategies to tackle rising Re impact</a><br>Times of India, India - 5 hours ago<br>For instance, Ranbaxy's US-based facility Ohm Labs is catering to US markets, Terapia in Romania to Europe and CIS countries, Be-Tabs Pharmaceuticals to the ...

::Read the Full Article